A Study of XZB-0004 in Patients With Solid Tumors

Clinical trial NCT05772455 · RECRUITING

Trial details

NCT number: NCT05772455
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor NSCLC

Start date: 2023-03-24
Primary completion: 2025-06-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.